Cagrilintide/semaglutide
A Research Study to Compare Blood Levels of Cagrilintide After Multiple Doses of Different Versions of Cagrilintide in Adults With Overweight or Obesity
Novo Nordisk · Phase 1 · Recruiting · Enrollment 234
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Cagrilintide B and Placebo Semaglutide I | n/r | n/r | n/r | n/r |
| Cagrilintide D-Injection site 1 | n/r | n/r | n/r | n/r |
| Cagrilintide D-Injection site 2 | n/r | n/r | n/r | n/r |
| Cagrilintide D-Injection site 3 | n/r | n/r | n/r | n/r |
Not shown
- Cagrilintide B and Placebo Semaglutide I: endpoint not reported
- Cagrilintide D-Injection site 1: endpoint not reported
- Cagrilintide D-Injection site 2: endpoint not reported
- Cagrilintide D-Injection site 3: endpoint not reported